🔎 Trials Near Me

Dachaigh › Leukemia myeloid geur › Sgìre Cholumbia › Washington

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Washington, DC

Tha 24 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Washington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A’ fastadhÌre 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564390

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

A’ fastadhÌre 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06904066

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • Center for Cancer and Blood Disorders, Bethesda · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06852222

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

A’ fastadhÌre 3
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mìle air falbh
6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

Longitudinal Studies of Patient With FPDMM

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
1 Day – 100 Years · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT03854318

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 12 gu 120 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT05436418

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

A’ fastadhSgrùdadh amharc
  • The Center for Cancer and Blood Disorders, Bethesda · 7 mìle air falbh
Aoisean 0 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07154823

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • Children's National - Main Hospital, Washington D.C.
29 Days – 21 Years · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05183035

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

A’ fastadhÌre 1
  • Childrens National Medical Center, Washington D.C.
6 Months – 80 Years · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT02203903

Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
1 Day – 120 Years · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT05350748

Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT05588154

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Children's National Medical Center, Washington D.C.
  • Nih/Niaid, Bethesda · 7 mìle air falbh
  • Nih/Nhlbi, Bethesda · 7 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

A’ fastadhSgrùdadh amharc
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
1 Month – 120 Years · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT07019155

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

A’ fastadhÌre 1/2
  • The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT04068597

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Cancer Support Community Research & Training Institute, Washington D.C.
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT02333604

Massage Impact on Sleep in Pediatric Oncology

A’ fastadh
  • Children's National Hospital, Washington D.C.
Aoisean 12 gu 21 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06892158

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A’ fastadhÌre 1/2
  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

A’ fastadhÌre 1/2
  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Màrt 2026 · NCT04990102

Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile

Sgrùdaidhean eile ann an Washington

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.